OPPM
GBT

Opus Point Partners Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Opus Point Partners Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$460K Hold
9,479
– – 0.83% 30
2019
Q2 		$499K Hold
9,479
– – 0.74% 34
2019
Q1 		$502K Buy
+9,479
New +$466K 0.68% 34

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Opus Point Partners Management's GBT Position: Q3 2019 in Review

Opus Point Partners Management held its Global Blood Therapeutics, Inc. (GBT) position steady in Q3 2019 at 9,479 shares worth $460K. The position accounts for 0.83% of the portfolio, ranked #30.

Opus Point Partners Management first reported a position in GBT in Q1 2019 and has held it in 3 quarters since. The position peaked at $502K in Q1 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Opus Point Partners Management held 9,479 shares of Global Blood Therapeutics, Inc. worth $460K as of Q3 2019.
  • Opus Point Partners Management left its Global Blood Therapeutics, Inc. share count unchanged in Q3 2019.
  • Global Blood Therapeutics, Inc. made up 0.83% of Opus Point Partners Management's portfolio in Q3 2019, its #30 holding.
  • Opus Point Partners Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and has held it in 3 quarters since.
  • Opus Point Partners Management's Global Blood Therapeutics, Inc. position peaked at $502K in Q1 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.